Hideki Matsui

发表

Fusion Research Development focused on ITER and Related Recent Progress

Kunioki Mima, Satoshi Konishi, Mitsuru Kikuchi, 2007 .

2A1-P01 Effects of visual illusion on motion of fingertip and control of contact force(Informative Motion & Motion Media)

Nobuyasu Tomokuni, Hideki Matsui, Jian Huang, 2012 .

Visualization Strategy on the Earth Simulator for Large-Scale Unstructured Data Sets of GeoFEM

Hiroshi Okuda, Issei Fujishiro, Li Chen, 2002 .

1G2-2 手指麻痺者の指動作を実現するための腱構造を有するパワーグローブの開発(OS1-1:ウェアラブルアシストシステムI,オーガナイズドセッション)

Shunji Moromugi, Takakazu Ishimatsu, Yuki Miyazaki, 2009 .

2P2-Q13 Measurement of Kinesthesia Information and Contact Force at the Human Fingertip During Tracing Movement(Informative Motion & Motion Media)

Nobuyasu Tomokuni, Hideki Matsui, Jian Huang, 2011 .

True fungi isolated from insects collected in food-related facilities in Aichi Prefecture, Japan

Hideki Matsui, Haruka Kawaguchi, Tomoki Sumino, 2010 .

2P2-E03 Powered glove for people with paralysis of finger : A tool to encourage social participation of cervical cord injury patients(Rehabilitation Robotics and Mechatronics)

Shunji Moromugi, Takakazu Ishimatsu, Makoto Ninomiya, 2011 .

Electron beam mask writer EBM-7000 for hp 32nm generation

Seiichi Tsuchiya, Takashi Kamikubo, Noriaki Nakayamada, 2009, Photomask Technology.

118 人間指先トレーシング運動の画像計測(情報・知能・精密機器II)

Nobuyasu Tomokuni, Kazuya Sato, Hideki Matsui, 2011 .

The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.

Koji Ono, Shinji Kawabata, Hideki Matsui, 2014, Biomaterials.

Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder.

Hideki Matsui, K. Tomizawa, H. Matsui, 2007, Acta medica Okayama.

Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.

Hideki Matsui, Shoji Fukumoto, Midori Ono, 2011, Journal of medicinal chemistry.

FK506, a Ca2+/calmodulin-dependent phosphatase inhibitor, inhibits the induction of long-term potentiation in the rat hippocampus

Hideki Matsui, Yasushi Hayashi, K. Tomizawa, 1996, Neuroscience Letters.

Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice.

Hideki Matsui, Satoshi Kimura, Sayaka Watanabe, 2011, The Journal of clinical investigation.

Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).

Shiroh Futaki, Hideki Matsui, Ikuhiko Nakase, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Sequencing analysis of a putative human O-sialoglycoprotein endopeptidase gene (OSGEP) and analysis of a bidirectional promoter between the OSGEP and APEX genes.

Hideki Matsui, Hiroaki Ayabe, Shogo Ikeda, 2002, Gene.

[Protein transduction by poly-arginine].

Hideki Matsui, K. Tomizawa, M. Matsushita, 2003, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

HIV‐1 inhibits long‐term potentiation and attenuates spatial learning

Hideki Matsui, Sheng-tian Li, K. Tomizawa, 2004 .

Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists.

Atsushi Mizukami, Jun Fujimoto, Koji Fuji, 2014, Bioorganic & medicinal chemistry.

Critical differences in magnitude and duration of N-methyl D-aspartate(NMDA) receptor activation between long-term potentiation (LTP) and long-term depression (LTD) induction.

Hideki Matsui, Naoki Taniike, K. Tomizawa, 2008, Acta medica Okayama.

Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists.

Atsushi Mizukami, Hideki Matsui, Shoji Fukumoto, 2013, Bioorganic & medicinal chemistry.